U.S. Office — Brooklyn, NY · Mon–Fri 9:00–18:00 ET
Direct: +1 (347) 567-0781 · Email: info@sucotondusa.com
ProductsAboutCertificationsVerify FactoryBlogContact
Custom Development · Private Label

Design the vitamin C claim around the actual source, matrix and time point.

Sucotond USA coordinates non-confidential feasibility review for custom vitamin C gummies. The review separates source-compound input from declared vitamin C, then links serving, acidity and sensory design, assay, commercial package, stability protocol and label approval.

This is a custom-project service page, not a claim that one stocked source, formula, amount, overage, method or shelf life fits every project.

Functional gummy production and processing areaProject Starting Point
SourceExact ingredient and composition
Nutrient basisVitamin C per serving
MatrixAcidity, flavor and co-ingredients
AssayMethod and gummy matrix defined
StabilityCommercial pack and time points
MOQ and timingConfirmed after feasibility
Current service status: open for non-confidential custom-project review. This page does not identify an approved Sucotond vitamin C source, formula, overage or shelf life. Those decisions require the actual material, matrix, method, package and evidence plan.
Four Separate Axes

“Vitamin C gummy” is not yet a manufacturing specification

Source identity

Name L-ascorbic acid, a specific mineral ascorbate or another reviewed source and supplier material.

Declared nutrient

Record vitamin C per serving separately from source-compound weight and any mineral contribution.

Acidity and matrix

Review the complete acid, gelling, sweetener, flavor, color and co-ingredient system.

Time and package

Define when the claim must be met and which commercial product-package system supports it.

Claims boundary: this page makes no immune, antioxidant, cold-prevention, absorption-superiority, disease, safety or efficacy promise. Public references do not establish a Sucotond source, formula, assay or stability result.
Before a Quote

Six decisions connect formulation to shelf-life evidence

1. Define the vitamin source

  • Exact ingredient, supplier and grade
  • Composition and any mineral contribution
  • Incoming identity and specification records

2. Define the serving

  • Vitamin C per serving and units
  • Gummies per serving and piece mass
  • Source input and calculation basis

3. Balance the matrix

  • Pectin or gelatin direction
  • Acid profile, sweetener and flavor targets
  • Colors, coatings and co-ingredients

4. Define the assay

  • Analyte, method and sample preparation
  • Actual finished gummy matrix
  • Units, sampling and acceptance rule

5. Design stability

  • Commercial bottle, closure and count
  • Storage conditions and time points
  • Vitamin C plus agreed physical/microbial attributes

6. Reconcile the label

  • Supplement Facts and ingredient names
  • Claims, directions and destination market
  • Final artwork owner and change control
Evidence Timeline

A time-zero result is only the first checkpoint

Supplier material

Confirm identity, composition, grade, lot records and storage.

Approved formula

Lock source inputs, serving, matrix and label calculation basis.

Commercial batch

Connect process and sampling to the master and batch records.

Initial release

Review the matrix-appropriate result against the specification.

Stability points

Evaluate the same commercial product-package over defined time.

Public Evidence

Use nutrient references without turning them into product claims

What the August 2026 vitamin C gummy testing can—and cannot—tell a buyer

NOW's report, dated August 19, 2026, describes HPLC testing by NOW and Alkemist Labs of samples bought in June. It reports 13 of a listed 25-product group meeting label claims, and five separately discussed legacy brands passing. NOW's own product appears in the listed group. This targeted selection is not a random market survey or evidence about Sucotond.

NOW also predicted that four passing products could fall below their claims before expiry, based on earlier stability work. That is a prediction, not observed expiry testing of those products. Do not use it as a universal degradation rate or overage rule.

  • Comparable result: ask for sample identity, analytical scope and the same per-piece or per-serving basis as the proposed label.
  • Comparable time point: separate release data, actual stored-sample results and forecasts; record the commercial package and conditions.
  • Comparable acceptance: agree who reviews the evidence and what happens when a timepoint misses the specification.

Use these fields with the lab-report checklist. A public competitor study does not validate a proposed formula or demonstrate our manufacturing performance.

Name the source precisely

The NIH Office of Dietary Supplements identifies vitamin C as a water-soluble vitamin and discusses L-ascorbic acid and supplement forms including mineral ascorbates. That context supports a source-specific brief; it does not rank one source for every gummy or establish a Sucotond result.

NIH ODS: Vitamin C — Health Professional Fact Sheet

Reconcile the nutrient to Supplement Facts

21 CFR 101.36 provides the current federal dietary-supplement nutrition-labeling framework. The final serving, declared vitamin C amount, ingredient naming and claims must match the approved formula and responsible-firm review.

21 CFR 101.36 — Nutrition labeling of dietary supplements

Buyer FAQ

Vitamin C gummy project questions

Are ascorbic acid and mineral ascorbates the same formula input?

No. Record the exact source, supplier material, composition and any mineral contribution; keep declared vitamin C as a separate controlled field.

Is buffered vitamin C automatically better?

No universal superiority claim is made. Source, acidity, sensory targets, nutrient basis, assay, label and package require project review.

Can a time-zero assay establish shelf life?

No. Shelf life requires a defined product-package system, conditions, protocol, time points, attributes and acceptance rules.

Is an overage a standard percentage?

No fixed overage is offered here. Any adjustment needs technical rationale, legal and quality review, process understanding and project evidence.

What should the RFQ include?

Include source preference, vitamin C target, serving, matrix and acidity direction, market, assay and stability expectations, package, volume stage and timing.

Non-Confidential Project Intake

Request a vitamin C gummy feasibility map

Share the vitamin C source and target, serving, acid and gummy system, package, market, assay and stability expectations, volume stage and timing. The review identifies open questions; it is not a formula, quote, overage, result or production commitment.

Sucotond USA

U.S. sales and project coordination

Address7624 17th Ave
Brooklyn, NY 11214

Do not submit confidential formula details before an NDA is in place. By submitting, you agree that Sucotond USA may use these details to evaluate and respond to the inquiry. Privacy notice.

Thanks — your brief was received.
The project inputs are ready for internal review.
Related Micronutrient Programs

Separate source input, declared nutrient and time-point evidence

Compare the project file for elemental calcium and compound composition, elemental iron and warning review, and custom vitamin D3 plus K2 gummy formulation. Use the gummy shelf-life and stability checklist to define package and time-point evidence.